These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5845495)

  • 21. Studies on copper metabolism. XXIX. A critical analysis of serum copper and ceruloplasmin concentrations in normal subjects, patients with Wilson's disease and relatives of patients with Wilson's disease.
    CARTWRIGHT GE; MARKOWITZ H; SHIELDS GS; WINTROBE MM
    Am J Med; 1960 Apr; 28():555-63. PubMed ID: 13808058
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of penicillamine and dimercaprol on turnover of copper in patients with Wilson's disease.
    OSBORN SB; WALSHE JM
    Lancet; 1958 Jan; 1(7011):70-3. PubMed ID: 13503211
    [No Abstract]   [Full Text] [Related]  

  • 23. The treatment of hepatolenticular degeneration.
    CUMINGS JN
    Proc R Soc Med; 1959 Jan; 52(1):62-4. PubMed ID: 13623852
    [No Abstract]   [Full Text] [Related]  

  • 24. DIMERCAPROL for hepatolenticular degeneration.
    Lancet; 1952 Jan; 1(6700):199-200. PubMed ID: 14889814
    [No Abstract]   [Full Text] [Related]  

  • 25. Dimercaprol in the pre-neurological stage of Wilson's disease (hepatolenticular degeneration).
    WARNOCK CG; NEILL DW
    J Neurol Neurosurg Psychiatry; 1954 Feb; 17(1):70-4. PubMed ID: 13131080
    [No Abstract]   [Full Text] [Related]  

  • 26. [COPPER METABOLISM AND WILSON'S DISEASE].
    LANGE J
    Verh Dtsch Ges Inn Med; 1964; 70():330-7. PubMed ID: 14294237
    [No Abstract]   [Full Text] [Related]  

  • 27. Inborn errors of metabolism in neurology (Wilson's disease, Refsum's disease and lipidoses).
    Cumings JN
    Proc R Soc Med; 1971 Mar; 64(3):313-22. PubMed ID: 4101505
    [No Abstract]   [Full Text] [Related]  

  • 28. FILTERABLE AND NON-FILTERABLE SERUM COPPER. (2). STUDIES WITH 64CU.
    OSBORN SB; WALSHE JM
    Clin Sci; 1964 Apr; 26():213-7. PubMed ID: 14161054
    [No Abstract]   [Full Text] [Related]  

  • 29. THE ROLE OF COPPER IN THE CATALYTIC ACTION OF LACCASE AND CERULOPLASMIN.
    BROMAN L; MALMSTROEM BG; AASA R
    Biochim Biophys Acta; 1963 Nov; 75():365-76. PubMed ID: 14104946
    [No Abstract]   [Full Text] [Related]  

  • 30. [Ceruloplasmin in hepatolenticular degeneration and the effect of copper on oxidative activity of ceruloplasmin].
    Wald I; Galewicz A; Górska D
    Neurol Neurochir Pol; 1971; 5(5):622-9. PubMed ID: 4258660
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatolenticular degeneration; review of the literature and report of a case with dimercaprol (BAL) therapy.
    SCHECHTER MM; JONES CA
    AMA Arch Intern Med; 1953 Apr; 91(4):541-9. PubMed ID: 13039608
    [No Abstract]   [Full Text] [Related]  

  • 32. Lipid peroxidation and the cytotoxicity of copper.
    Hochstein P; Kumar KS; Forman SJ
    Ann N Y Acad Sci; 1980; 355():240-8. PubMed ID: 6263142
    [No Abstract]   [Full Text] [Related]  

  • 33. BIOCHEMICAL ASPECTS OF COPPER AND AROMATIC AMINES IN RELATION TO THE EXTRAPYRAMIDAL SYSTEM.
    WALAAS E; WALAAS O
    Acta Neurol Scand Suppl; 1963; 39(4):SUPPL4:84-94. PubMed ID: 14057524
    [No Abstract]   [Full Text] [Related]  

  • 34. Observations on ceruloplasmin in Wilson's disease.
    SASS-KORTSAK A; CHERNIAK M; GEIGER DW; SLATER RJ
    J Clin Invest; 1959 Oct; 38(10 Pt 1-2):1672-82. PubMed ID: 14441876
    [No Abstract]   [Full Text] [Related]  

  • 35. Zinc-induced deterioration in Wilson's disease aborted by treatment with penicillamine, dimercaprol, and a novel zero copper diet.
    Walshe JM; Munro NA
    Arch Neurol; 1995 Jan; 52(1):10-1. PubMed ID: 7826266
    [No Abstract]   [Full Text] [Related]  

  • 36. [On BAL treatment of hepatolenticular degeneration].
    KNUPPEL H
    Med Klin; 1956 Jan; 51(3):107-8. PubMed ID: 13296803
    [No Abstract]   [Full Text] [Related]  

  • 37. Exchange of ceruloplasmin copper with ionic Cu64 with reference to Wilson's disease.
    SCHEINBERG IH; MORELL AG
    J Clin Invest; 1957 Aug; 36(8):1193-201. PubMed ID: 13463081
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatolenticular degeneration; follow-up report of a case treated with dimercaprol (BAL), potassium sulfide, and high-protein diet.
    FERRISS GS; BERRY S
    AMA Arch Intern Med; 1957 Apr; 99(4):656-9. PubMed ID: 13410170
    [No Abstract]   [Full Text] [Related]  

  • 39. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
    D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N
    Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
    [No Abstract]   [Full Text] [Related]  

  • 40. [CERULOPLASMIN CONTENT IN PATIENTS WITH HEPATOCEREBRAL DYSTROPHY AND IN THEIR HEALTHY RELATIVES].
    MITTELSHTEDT AA; BAUMAN LK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1964; 64():819-21. PubMed ID: 14235907
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.